Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-31 @ 2:38 PM
Study NCT ID:
NCT01799993
Status:
COMPLETED
Last Update Posted:
2018-07-23
First Post:
2013-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-07
Completion Date Type:
ACTUAL
First Submit Date:
2013-02-25
First Submit QC Date:
None
Study First Post Date:
2013-02-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-27
Results First Submit QC Date:
None
Results First Post Date:
2018-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-19
Last Update Post Date:
2018-07-23
Last Update Post Date Type:
ACTUAL